Insmed Incorporated (INSM)
NASDAQ: INSM · Real-Time Price · USD
81.45
+0.44 (0.54%)
Feb 5, 2025, 4:00 PM EST - Market closed
Insmed Stock Forecast
Stock Price Forecast
The 14 analysts with 12-month price forecasts for Insmed stock have an average target of 84.29, with a low estimate of 42 and a high estimate of 105. The average target predicts an increase of 3.49% from the current stock price of 81.45.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 22, 2024.
Analyst Ratings
The average analyst rating for Insmed stock from 16 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 9 | 9 | 9 | 9 |
| Buy | 7 | 7 | 7 | 7 | 7 | 7 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 16 | 16 | 16 | 16 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy Maintains $74 → $83 | Buy | Maintains | $74 → $83 | +1.91% | Nov 22, 2024 |
| Truist Securities | Truist Securities | Strong Buy Reiterates $100 → $105 | Strong Buy | Reiterates | $100 → $105 | +28.92% | Nov 1, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $90 | Strong Buy | Reiterates | $90 | +10.50% | Nov 1, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $85 → $100 | Strong Buy | Maintains | $85 → $100 | +22.78% | Oct 11, 2024 |
| B of A Securities | B of A Securities | Strong Buy Maintains $84 → $86 | Strong Buy | Maintains | $84 → $86 | +5.59% | Oct 9, 2024 |
Financial Forecast
Revenue This Year
365.47M
from 305.21M
Increased by 19.74%
Revenue Next Year
523.22M
from 365.47M
Increased by 43.16%
EPS This Year
-5.52
from -5.34
EPS Next Year
-4.51
from -5.52
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 384.3M | 679.7M | 1.3B | |||
| Avg | 365.5M | 523.2M | 1.0B | |||
| Low | 344.0M | 425.6M | 642.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 25.9% | 86.0% | 141.2% | |||
| Avg | 19.7% | 43.2% | 98.0% | |||
| Low | 12.7% | 16.5% | 22.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -5.41 | -3.28 | -0.92 | |||
| Avg | -5.52 | -4.51 | -2.55 | |||
| Low | -5.56 | -5.60 | -4.27 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.